SureTrader
Home > Boards > US OTC > Miscellaneous > Fuse Science, Inc. (DROP)

IMO, what is happening to the price is

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
kylelele Member Profile
 
Followed By 1
Posts 972
Boards Moderated 0
Alias Born 02/28/13
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/4/2016 5:01:05 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) "Edgar (US Regulatory)" - 12/30/2015 10:05:47 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/3/2015 5:30:29 PM
Amended Quarterly Report (10-q/a) "Edgar (US Regulatory)" - 9/15/2015 4:15:08 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/14/2015 11:46:33 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/20/2015 2:59:18 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 5/15/2015 4:30:58 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 3/24/2015 11:32:01 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 3/9/2015 4:10:32 PM
Gaapko IR Initiates Analyst Coverage on Helios and Matheson Analytics (NASDAQ: HMNY) with $8.25 Valuation Issued by Small Cap... "InvestorsHub NewsWire" - 2/25/2015 7:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 2/23/2015 5:25:40 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 2/17/2015 4:20:03 PM
kylelele   Wednesday, 06/05/13 10:48:16 AM
Re: None
Post # of 88059 
IMO, what is happening to the price is exactly what people are saying on this board. People had a chance to see the test data and are coming to realize that the pharma applications either aren't feasible at all or aren't nearly as close to being a reality as original thought.

The first round of testing was on caffeine only. Caffeine showed around 7% delivery with FUSE's tech. Then they took the testing to multiple compounds for the 2nd round. I'm sure they were hoping the other compounds would be close to caffeine's delivery, but instead, the highest they got with any of the other compounds was 1.5%. This is around 20%. How could this not be looked at as dissapointing??

I'm bummed guys. In my opinion, the data yesterday shows that we are an energy supplement company in a field of numerous others. Our hopes now are that Tiger, DJ, Cheban, et al can make us stand out and get some of the market share of 5-hour and others.

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist